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Predicted effects of observed 
changes in the mRNA and 
microRNA transcriptome of lung 
neutrophils during S. pneumoniae 
pneumonia in mice
John C. Gomez1,2,3, Hong Dang2, Matthew Kanke4, Robert S. Hagan  1,3,5, Jason R. Mock1,3,5, 
Samir N. P. Kelada  4, Praveen Sethupathy4 & Claire M. Doerschuk1,2,3,5
The complex role of neutrophils in modulating the inflammatory response is increasingly appreciated. 
Our studies profiled the expression of mRNAs and microRNAs (miRs) in lung neutrophils in mice 
during S. pneumoniae pneumonia and performed in depth in silico analyses. Lung neutrophils were 
isolated 24 hours after intratracheal instillation of PBS or S. pneumoniae, and differentially expressed 
(DE) mRNAs and miRs were identified. Lung neutrophils from mice with S. pneumoniae pneumonia 
contained 4127 DE mRNAs, 36% of which were upregulated at least 2-fold. During pneumonia, 
lung neutrophils increase expression of pattern recognition receptors, receptors for inflammatory 
mediators, transcription factors including NF-κB and AP-1, Nrf2 targets, cytokines, chemokines and 
other inflammatory mediators. Interestingly, neutrophils responded to Type I interferons, whereas they 
both produced and responded to Type II interferon. Expression of regulators of the inflammatory and 
immune response was verified at the mRNA and protein level. Of approximately 1100 miRs queried, 31 
increased and 67 decreased more than 2-fold in neutrophils from S. pneumoniae pneumonia. Network 
analyses of potential DE miR-target DE mRNA interactions revealed candidate key regulatory miRs. 
Thus, S. pneumoniae modulates mRNA and miR expression by lung neutrophils, increasing their ability 
to respond and facilitating host defense.
During inflammation, neutrophils are recruited from the circulation to sites of injury, where they kill invading 
pathogens through phagocytosis and release of reactive oxygen species, proteases and other effectors. In recent 
years, the complexity of the neutrophil response has become increasingly clear. Rather than being simply highly 
motile phagocytic bags of enzymes, neutrophils are in fact capable of a range of responses that encompass alter-
ations in neutrophil adhesiveness and motility, modulation of cell death and survival pathways, and production 
of cytokines and other mediators. The active and dynamic neutrophil response during inflammation is associated 
with changes in gene expression1, 2. Neutrophils also express miRs, short single-stranded RNAs that recognize 
sequences in the 3′ untranslated region (UTR) of mRNAs and cause post-transcriptional silencing of the target 
mRNA by suppressing protein synthesis and/or inducing mRNA degradation3. As with mRNAs, miR expression 
in neutrophils can be modulated during development, apoptosis, exercise, during infection or after adminis-
tration of inflammatory mediators such as LPS4–16. Transcription factors regulate transcription of mRNAs and 
microRNAs (miRs) by binding to DNA sequences adjacent to the target genes and directing recruitment of RNA 
polymerases and other enzymes. Because each transcription factor usually regulates more than one gene, which 
in turn may modify the expression and function of other downstream genes, transcription factors are key players 
in determining the host response during infection.
1Center for Airways Disease, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. 2Cystic Fibrosis/Pulmonary 
Research and Treatment Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. 3Marsico Lung Institute, 
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. 4Department of Genetics, University of North Carolina 
at Chapel Hill, Chapel Hill, NC, USA. 5Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, 
USA. Correspondence and requests for materials should be addressed to C.M.D. (email: cmd@med.unc.edu)
Received: 6 April 2017
Accepted: 24 August 2017
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2SCIeNTIFIC RepoRts | 7: 11258  | DOI:10.1038/s41598-017-11638-7
S. pneumoniae is the most common pathogen causing community-acquired pneumonia and is associated with 
a cellular infiltrate composed primarily of neutrophils in the acute stages17. In this study, we tested the hypothesis 
that expression of mRNAs and miRs by neutrophils in the lungs is altered during pneumonia induced by S. pneu-
moniae. Our results presented herein demonstrate that S. pneumoniae modulates mRNA and miR expression by 
lung neutrophils, which likely shape the inflammatory and immune response against this pathogen and subse-
quent resolution and repair in the lungs. Identifying the changes in mRNAs and miRs induced by this organism 
provides an unprecedented opportunity to map the signaling pathways that are most critical to the host response 
to infection. Although studies have addressed changes in gene expression in blood or bone marrow neutrophils 
following ex vivo stimulation, we believe these are the first studies profiling gene expression in neutrophils iso-
lated from lung tissue with and without infection. Network-level characterization of miR-mediated regulation 
of mRNAs in neutrophils during pneumonia can facilitate the development of improved therapies for fighting 
infections and diseases in which neutrophils play a critical role.
Results
Neutrophils were isolated from lung digests 24 h after intratracheal instillation of S. pneumoniae or PBS. The 
results of the analyses profiling both mRNA and miR expression in the same neutrophils are described below, 
followed by integration of mRNA and miR expression into a signaling network schema.
mRNA expression profiling. Microarray analysis of mRNA expression in lung neutrophils from mice that 
received either S. pneumoniae or PBS reveals that S. pneumoniae induces widespread changes in neutrophil gene 
expression. Dimension reduction using Principal Component Analysis reveals that the top 3 principal components 
(PCs) account for 83% of the total variance, with the first component (PC#1) alone accounting for 57% of the var-
iance and showing clear separation between the PBS- and S. pneumoniae-treated samples (Fig. 1a). Unsupervised 
hierarchical clustering from the whole array data or differentially expressed genes shows that samples of neutro-
phils from lungs with PBS and S. pneumoniae cluster into their respective groups, indicating that samples given 
the same stimulus (PBS or S. pneumoniae) have broadly similar patterns of expression (Fig. 1b).
Figure 1. (a) Principal Component Analysis (PCA) of mRNA expression data showing the contributions of 
the top three principal components to the variance in mRNA expression by lung neutrophils from mice that 
received PBS compared to S. pneumoniae (n = 4 in each group). The top 3 principal components (PC) together 
account for 83.1% of the total variance, with the top 3 PCs each accounting for 57.4%, 16.1% and 9.64% of the 
total variance, respectively. (b) Unsupervised hierarchical clustering of DE mRNAs in lung neutrophils from 
mice that received PBS or S. pneumoniae. DE mRNAs were identified using filtering criteria as described in 
the text. The heat map depicts the standardized intensity values for 4127 DE mRNAs after normalization and 
standardization. Mean expression was set at zero, and expression levels scaled to one standard deviation (bright 
blue for low expression levels and bright red for high expression levels). Each row represents a sample from a 
mouse given PBS or S. pneumoniae (as labeled) and each column represents a DE mRNA. The dendrograms 
show the results of hierarchical clustering across samples (left) or across DE mRNAs (top).
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The expression levels of 9,939 interrogated mRNAs were significantly different in lung neutrophils from 
mice with S. pneumoniae pneumonia compared with those from mice given PBS at an FDR adjusted p value 
(q-value) ≤ 0.05. Of these, 4,127 were changed by at least 2-fold and were designated as differentially expressed 
(DE) mRNAs. Of the DE transcripts, 1495 (36%) were upregulated at least 2-fold during S. pneumoniae pneu-
monia and 2632 (64%) were downregulated. Gene Set Enrichment Analysis (GSEA) using Gene Ontology (GO) 
molecular function terms indicated that genes involved in host defense and immune processes showed highly 
significant enrichment in samples from mice given S. pneumoniae, whereas metabolic and motor pathways were 
enriched in PBS (Table 1).
Although not listed among the top 25 gene sets shown in Table 1, gene sets pertaining to adaptive immu-
nity were also significantly enriched during pneumonia (FDR < 1.70 × 10−5), including GO: 0072678 (T cell 
migration), GO: 0002824 (positive regulation of adaptive immune response based on somatic recombination 
of immune receptors built from immunoglobulin superfamily domains) and GO: 0002821 (positive regulation 
of adaptive immune response). These results indicate that neutrophils may play a role in shaping the subsequent 
adaptive immune response to S. pneumoniae, perhaps through effects on lymphocyte recruitment and activa-
tion. For example, expression of various chemokines that regulate lymphocyte chemotaxis are highly upregulated 
(Ccl2, Ccl5, Cxcl9, Cxcl10; see Supplementary Table 1) and the gene for the costimulatory receptor CD86 is upreg-
ulated 2.7 fold (FDR = 0.05).
Neutrophils upregulate expression of inflammatory genes. Among the gene sets that were identified as being 
highly significantly enriched during pneumonia (Table 1) were several large gene sets comprising numerous 
inflammatory genes (Supplementary Figure). Lung neutrophils from mice with pneumonia showed increased 
expression of genes that encode a number of mediators, including the important pro-inflammatory cytokines 
IL-1α, IL-6, TNF and CXCL1 (KC) (Supplementary Table 1). The ability of neutrophils to respond to inflam-
matory stimuli is enhanced during pneumonia, as evidenced by the increased expression of pattern recognition 
receptors and receptors for cytokines and other inflammatory mediators. Anti-inflammatory genes including Il10 
and Il1rn are also increased at this time (Supplementary Table 1). Upregulation of the Cxcl1, Cxcl5, Cxcl9 Cxcl11, 
Tnf, Il1a, Il6 and Il10 was confirmed in an independent cohort of lung neutrophil samples isolated from mice 
given PBS or S. pneumoniae using TaqMan assays and RT-qPCR (Supplementary Table 2). Increased expression of 
several DE genes that are important in the inflammatory and immune response were also validated at the protein 
level, namely the cytokines IFN-γ and TNF, the adhesion molecules ICAM-1, CD11c, CD11b and CD103, and 
the Fc receptor CD64 (Supplementary Table 3).
Induction of type I interferon (IFN) response. Induction of the type I IFN response in the lung during S. pneu-
moniae infection was apparent in the upregulation of type I IFN-responsive genes in neutrophils. The IFN-α/β 
Gene sets enriched in S. pneumoniae samples Gene sets enriched in PBS samples
(GO:0035456) response to interferon-beta (GO:0042384) cilium assembly
(GO:0002237) response to molecule of bacterial origin (GO:0044782) cilium organization
(GO:0032496) response to lipopolysaccharide (GO:0060271) cilium morphogenesis
(GO:0071219) cellular response to molecule of bacterial origin (GO:0001578) microtubule bundle formation
(GO:0071222) cellular response to lipopolysaccharide (GO:0003341) cilium movement
(GO:0071216) cellular response to biotic stimulus (GO:0035082) axoneme assembly
(GO:0035458) cellular response to interferon-beta (GO:0010927) cellular component assembly involved in morphogenesis
(GO:0032655) regulation of interleukin-12 production (GO:0030031) cell projection assembly
(GO:0034097) response to cytokine (GO:0007018) microtubule-based movement
(GO:0001819) positive regulation of cytokine production (GO:0007224) smoothened signaling pathway
(GO:0032615) interleukin-12 production (GO:0007368) determination of left/right symmetry
(GO:0042832) defense response to protozoan (GO:0070286) axonemal dynein complex assembly
(GO:0045088) regulation of innate immune response (GO:0042073) intraciliary transport
(GO:0045087) innate immune response (GO:0021532) neural tube patterning
(GO:0034341) response to interferon-gamma (GO:0021904) dorsal/ventral neural tube patterning
(GO:0045089) positive regulation of innate immune response (GO:0009799) specification of symmetry
(GO:0071345) cellular response to cytokine stimulus (GO:0009855) determination of bilateral symmetry
(GO:0019882) antigen processing and presentation (GO:0048858) cell projection morphogenesis
(GO:0031349) positive regulation of defense response (GO:0008589) regulation of smoothened signaling pathway
(GO:0032649) regulation of interferon-gamma production (GO:0003351) epithelial cilium movement
(GO:0002675) positive regulation of acute inflammatory response (GO:0032990) cell part morphogenesis
(GO:0019221) cytokine-mediated signaling pathway (GO:0021591) ventricular system development
(GO:0032609) interferon-gamma production (GO:0007017) microtubule-based process
(GO:0009617) response to bacterium (GO:0009062) fatty acid catabolic process
(GO:0001562) response to protozoan (GO:0036158) outer dynein arm assembly
Table 1. Top 25 molecular pathways significantly enriched in lung neutrophils from mice given PBS or  
S. pneumoniae. Gene Set Enrichment Analysis (GSEA) was done using gene sets from the Molecular Signatures 
Database (http://www.broadinstitute.org/gsea/index.jsp). FDR < 0.00005.
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receptor consists of two subunits, Ifnar1 and Ifnar2, both of which are abundantly expressed in unstimulated 
neutrophils. During pneumonia, lung neutrophils upregulated expression of Ifnar1 and Ifnar2 mRNA 2.3 and 
1.5 fold, respectively (FDR < 0.05). Furthermore, during pneumonia, lung neutrophils increased expression of a 
number of IFN-responsive genes, including the inflammatory mediators Ccl2, Ccl5, and Cxcl10, antiviral effector 
enzymes Oas1, Oas2, Oas3, and Ddx60, and transcription factors and signaling molecules involved in the inter-
feron pathway such as Irf1 and Stat1 (Supplementary Table 1). However, normalized log2 expression levels were 
low for the genes encoding IFN-α isoforms and IFN-β, and these genes were not induced 2-fold or more during 
pneumonia. In an independent set of samples assayed using RT-qPCR, Ifnar2 and the interferon-responsive genes 
Cxcl11, Ifit1, Irf5 and Isg15 were confirmed to be upregulated during pneumonia (Supplementary Table 2). Taken 
together, these studies suggest that neutrophils are well able to respond to type I IFNs through the IFN-α/β recep-
tor to produce target genes, but do not appear to be a major source of Type I IFNs at this time point.
Type II IFN (IFN-γ) production and activity. Consistent with our previous report4, the pleiotropic cytokine 
IFN-γ was upregulated 2.3-fold in lung neutrophils from mice given S. pneumoniae for 24 h compared with PBS 
controls (FDR = 0.02). Notably, GSEA identified “cellular response to IFN-γ” and “production of IFN-γ” among 
the GO biological processes significantly upregulated during pneumonia (FDR < 10−5, FWER p value < 0.001 
for both sets). Upregulated IFN-γ responsive genes included Nos2, Irf1, Ccl2, Ccl5, and Gbp2-3 (Supplementary 
Table 1). Neutrophils also upregulated genes that encode proteins in the IFN-γ signaling pathway, including 
Jak2 (3.3-fold) and Stat1 (3.5-fold), and genes that encode cytokines inducing IFN-γ production, including Il12a 
(25-fold) and Il18 (2.7-fold). Upregulation of the IFN-γ responsive genes Nos2 and Cxcl9 during pneumonia were 
confirmed by RT-qPCR in independent samples (Supplementary Table 2). Taken together, these results show 
that neutrophils simultaneously upregulate both production and sensing of Type II IFN, in contrast to type I IFN 
signaling for which sensing occurs but not production
The role of NF-κB. Numerous genes regulated by the transcription factor NF-κB were increased in neutrophils 
during S. pneumoniae pneumonia, including cytokines and chemokines, growth factors, receptors and intracel-
lular signaling molecules (Supplementary Table 1). Transcription factors that are either regulated by NF-κB or 
regulate NF-κB activation were also differentially expressed (Supplementary Table 1). Upregulation of genes for 
pattern recognition receptors that signal upstream of NF-κB activation (for example, Nod1, Nod2, Tlr2, Tlr4, Tlr6, 
Tlr7, Tlr9, Nlrp3), cytoplasmic signaling molecules that signal downstream of these receptors (Pycard, Casp1), 
and mRNAs coding for proteins that interact with NF-κB subunits to regulate activation (Nfkbia, Nfkbib, Nfkbie) 
indicate complex regulation of and by NF-κB in neutrophils during S. pneumoniae-induced pneumonia. Changes 
in the nucleic acid sensors were variable in lung neutrophils. DAI and RIG-I family expression levels increased, 
but curiously, MAVS was downregulated.
There were interesting changes in multiple pathways leading to NF-κB activation in neutrophils (Supplementary 
Table 1). S. pneumoniae leads to strong induction of the IKK-related kinases Ikbke and Tbk1 which we confirmed 
by RT-qPCR in an independent set of samples (Supplementary Table 2), whereas Chuk (IKKα) and Ikbkb (IKKβ) 
are not induced. While the role of IKKα and IKKβ in canonical and non-canonical NF-κB activation has been 
examined extensively, TBK1 has been shown to contribute to canonical and non-canonical NF-κB activation in 
some contexts while repressing NF-κB activation in others18–24. As noted in other tables, multiple transcriptional 
targets consistent with activation of TBK1 and IKKε were upregulated, for example, Irf7, Cxcl10, Ifit1, Mx1, Mx2 
and Oas-family members. Overall, these changes are consistent with increased TBK1 and IKKε kinase activity, as 
well as activation of Irf3/7 and the NF-κB pathways. Of note, many of these genes encode antiviral proteins (e.g., 
Mx1/2, IFITs, OAS) that to date have a less well-defined role in bacterial infections.
Both canonical and non-canonical IKKs require adaptor or scaffold proteins such as Ikbkg (NEMO), Tbk1bp1 
(also called SINTBAD), Azi2 (also called Nap1) and TANK to direct them to specific subcellular locations and 
assist in substrate binding21, 25, 26. S. pneumoniae caused significant upregulation of genes encoding NEMO, 
SINTBAD, TANK, and mild upregulation of OPTN and Azi2, but no change in the expression of the genes encod-
ing adaptors Calcoco2 (Ndp52), SQSTM1 (p62), RIOK, or DOK3. It is possible that selective expression of IKK 
adaptor proteins may direct the specificity of response in this infection model; namely, upregulation of NEMO, 
SINTBAD and TANK without upregulation of other scaffolds such as RIOK3 and DOK3 may facilitate high 
expression of NF-κB target genes (Il1a, Tnf, Nos2) and type I IFN responsive genes (Ifit1/2/3, Oas1/2/3, Gbp3) 
while limiting overall expression of IFNα and IFNβ themselves.
The role of AP-1. The transcription factor AP-1 is activated by cytokines, growth factors, inflammatory media-
tors, and other stimuli via MAPK signaling, and its function can be assessed by analysis of its target genes. Canonical 
AP-1 targets are upregulated in neutrophils at least 2-fold during S. pneumoniae pneumonia, indicating that AP-1 
contributes to the neutrophil transcriptional response to S. pneumoniae in the lungs (Supplementary Table 1).
The role of Nrf2 during pneumonia is evaluated by expression of its target genes. The redox-sensitive transcrip-
tion factor Nrf2 is highly expressed in lung neutrophils, and its mRNA expression does not change significantly 
during S. pneumoniae pneumonia (upregulated 1.3-fold, FDR = 0.09), consistent with post-translational regula-
tion of its function27, 28. The expression levels of known Nrf2-regulated genes are increased at least 2-fold in lung 
neutrophils by S. pneumoniae, including the redox enzymes and the validated direct targets of Nrf2, Sod2, Hmox1, 
Nqo1, and Txnrd1 (Supplementary Table 1). Several additional Nrf2-regulated genes were upregulated 1.5–1.9 fold 
(Supplementary Table 1). Upregulation of the Nrf2 target genes Nqo1 and Hmox1 were confirmed by RT-qPCR 
(Supplementary Table 2). However, other genes known to be positively regulated by Nrf2 are down-regulated 
during S. pneumoniae pneumonia, underlining the fact that the response to redox stress during pneumonia is 
multifactorial and complex (Supplementary Table 1). The number of differentially expressed Nrf2 regulated genes 
and the wide range of critical functions these genes perform indicate that the Nrf2-mediated response to oxidative 
stress is robust and likely to play an important role in regulating neutrophils during pneumonia29.
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Verification of mRNA profiling by RT-qPCR and flow cytometry. An independent cohort of lung 
neutrophil samples isolated from mice given PBS or S. pneumoniae was prepared, and TaqMan assays and 
RT-qPCR were used to confirm mRNAs and miRNAs identified in microarray profiling. These are discussed in 
depth in the sections above. In summary, upregulation of the mediators Cxcl1, Cxcl5, Cxcl9 Cxcl11, Tnf, Il1a, Il6 
and Il10 was confirmed (Supplementary Table 2). Interestingly, in the interferon signaling pathways, Ifnar2 and 
the interferon-responsive genes Cxcl11, Ifit1, Irf5 and Isg15 were verified to be upregulated during pneumonia 
(Supplementary Table 2), documenting that neutrophils are well able to respond to type I interferon signaling. 
Consistent with our previous studies regarding the role of IFNγ in neutrophils during S. pneumoniae pneumo-
nia30, we confirmed upregulation of the IFN-γ responsive genes Nos2 and Cxcl9. The Nrf2 target genes Nqo1 and 
Hmox1 were also verified by RT-qPCR (Supplementary Table 2).
Furthermore, increased expression of several DE genes that are important in the inflammatory and immune 
response were verified at the protein level, namely the cytokines IFN-γ and TNF, the adhesion molecules ICAM-
1, CD11c, CD11b and CD103, and the Fc receptor CD64 (Supplementary Table 3). These molecules are discussed 
above in sections appropriate to their function.
miR expression profiling. Microarray analysis reveals that S. pneumoniae induces widespread changes in 
neutrophil miR expression. The expression of over 1100 mouse miRs was profiled in neutrophils isolated from 
the lungs of mice given PBS or S. pneumoniae intratracheally. The data were normalized using two different 
approaches: least-variant set (LVS) and robust multiarray average (RMA). PCA showed that top three PCs 
account for 76% or 72% of total variance using normalization by LVS or RMA, respectively. The first principal 
component (PC#1) accounted for approximately 43% of the variance using both methods and showed clear dis-
tinction between PBS and S. pneumoniae-treated samples. Neutrophils from mice with S. pneumoniae pneumonia 
grouped separately from the PBS-exposed neutrophils (Fig. 2a). Hierarchical clustering using all profiled miRs or 
DE miRs shows that samples cluster into their respective treatment groups (Figs 2b and 3).
Comparison of neutrophils from mice given S. pneumoniae with those from mice given PBS reveals that the 
expression of 374 or 312 miRs is significantly different (FDR ≤ 0.05) after normalizing the data using LVS or 
RMA, respectively. A list of 98 consensus DE miRs was generated from these by selecting miRs that were changed 
at least 2-fold in both RMA- and LVS-normalized data sets (Supplementary Table 4). Of the 98 DE miRs, 31 
were upregulated and 67 were downregulated more than 2-fold in neutrophils from S. pneumoniae pneumonia 
compared with PBS controls. Three recently described miRs exhibited the highest fold-change (upregulation) 
using LVS or RMA normalization: mmu-miR-3093-3p on chromosome 3 (22.5 fold and 6.8-fold by RMA and 
LVS, respectively), mmu-miR-1896 on chromosome 13 (22-fold and 15-fold by RMA and LVS, respectively) 
and mmu-miR-1247-3p on chromosome 12 (21-fold and 8-fold by RMA and LVS, respectively). Of the down-
regulated miRs, mmu-miR-224-5p was down 7-fold and 31-fold by RMA and LVS, respectively. Mmu-miR-
449a-5p was down 10-fold by both RMA and LVS. Three members of the mir-34 family were downregulated: 
mmu-miR-34b-3p was down 11.5-fold and 18-fold by RMA and LVS, respectively, whereas mmu-miR-34b-5p 
and mmu-miR-34c-5p show relatively high expression and 7 to 9-fold downregulation during pneumonia. miR-
34 has been shown previously to be suppressed by NF-κB activation and is a known inhibitor of the inflammatory 
response31.
To validate the findings in the microarray expression profiling study, the expression of several miRs were 
measured using RT-qPCR in a different set of lung neutrophil samples generated in an independent study of 
mice given PBS or S. pneumoniae (Supplementary Table 5). Confirming the results of the gene profiling, 
mmu-miR-15b-5p and mmu-miR-223-3p were significantly upregulated during pneumonia, and mmu-miR-
34b-5p and mmu-miR-126-3p were significantly downregulated. The four members of the let7 family that were 
tested tended to be downregulated, although the differences did not reach significance except for mmu-let-7f-5p 
(Supplementary Table 5). The other tested miRs were up or downregulated during pneumonia as found by gene 
expression profiling, except for mmu-miR-125b-5p, which was significantly down in the profiling study but was 
widely variable in the verification study.
Some miRs are highly expressed in neutrophils from control mice with PBS instillation. Consistent with data 
in the literature describing miR expression in neutrophils or granulocytes, miR-223 and miR-142 are highly 
expressed in neutrophils from un-infected lungs13–15. Of the 25 most highly expressed miRs in neutrophils from 
mice given PBS, 16 were identified as being significantly changed during pneumonia using LVS normalization 
and 17 using RMA, and the majority of these were downregulated (13 of 16 using LVS, 12 of 17 using RMA, 
Table 2). Two of the most highly expressed miRs are only recently described: mmu-miR-3963 (on chromosome 
3)32, and mmu-miR-5100 (on chromosome 11)33–36. In fact, three of the genes identified by Chijiiwa and col-
leagues and Huang and colleagues as targets of mmu-miR-5100 are also significantly downregulated in neutro-
phils in pneumonia: Podxl (−3.67 fold), Rab6b (−2.37 fold), and Rab6a (−1.33 fold)34, 36, even though expression 
of this mmu-miR-5100 didn’t change.
mRNA and miR interactions and integration of their expression in a signaling network 
schema. Conserved DE miRs and their anti-correlated predicted targets during pneumonia. The data for con-
served miRs are presented in Supplementary Table 6 and those for poorly conserved miRs are in Supplementary 
Table 7. A greater proportion of DE predicted target genes of DE miRs are down rather than upregulated during 
pneumonia (Supplementary Tables 6 and 7). The anti-correlated DE mRNAs that are predicted targets for the 
conserved DE miRs and that are up or downregulated during pneumonia are listed in Supplementary Tables 8 
and 9, respectively. Targets for two conserved DE miRs are currently not in the TargetScanMouse 7.1 database: 
mmu-miR-126a-3p and mmu-miR-203-3p.
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To gain further insight into the role of miRs in regulating target mRNA expression, our subsequent analy-
sis focused largely on conserved miR families. Seven conserved DE miRs are upregulated during pneumonia 
and are expressed at moderate to high levels in lung neutrophils (average normalized mean expression above 
5): mmu-miR-1224-5p, mmu-miR-188-5p, mmu-miR-139-5p, mmu-miR-15b-5p, mmu-miR-721, mmu-miR-
18a-5p, and mmu-miR-130b-3p. Two of these, mmu-miR-721 and mmu-miR-130b-3p, belong to the same 
broadly conserved miR family and are therefore predicted to share target mRNAs in common. Our analysis iden-
tified 379 downregulated DE mRNAs that are predicted to be targets of these 7 upregulated conserved DE miRs, 
and 171 (45%) of these mRNAs are predicted targets of 2 or more of the DE miRs. Strikingly, 10 downregulated 
DE mRNAs are predicted targets of 4 or more of the upregulated DE miRs (Dip2c, Dynll2, Efnb2, Enah, Lrp2, 
Nfib, Sos2, Trim2, Wdr50, and Zbtb20), and several of these mRNAs act in processes that are likely to be critical in 
neutrophil function and host defense during infection, including gene transcription, cell migration and apoptosis 
(Supplementary Table 10).
There are 37 conserved DE miRs that are downregulated during pneumonia. These include 5 members of the 
broadly conserved let-7 family (mmu-let-7b-5p, mmu-let-7c-5p, mmu-let-7d-5p, mmu-let-7e-5p, and mmu-let-
7f-5p); 2 members of the miR-30 family (mmu-miR-30a-5p and mmu-miR-30c-5p), and 3 members of the miR-
34 family (mmu-miR-34a-5p, mmu-miR-34b-5p and mmu-miR-34c-5p).
Networks incorporating the changes in expression levels of conserved DE miRs and their DE predicted targets 
were constructed and visualized. DE miRs were screened for those belonging to conserved miR families and 
showing moderate or greater expression levels. Lists of miR-target connections between these DE miRs and 
their target DE mRNAs were compiled from TargetScanMouse 7.1 target predictions. The network based on 7 
Figure 2. (a) PCA of miR profiling data after normalization using LVS (left) or RMA (right) shows the 
contributions of the top three principal components to the variance in miR expression by lung neutrophils from 
mice that received PBS or S. pneumoniae. Together, the top three PCs account for 76% of the total variance after 
normalization using LVS or 72% of total variance after normalization using RMA. Using LVS normalization, 
the top 3 principal components each account for 42.7%, 20.6% and 12.9% of the total variance, respectively. 
Using RMA normalization, the top 3 principal components each account for 43.5%, 16.1% and 12.3% of the 
total variance, respectively. (b) Unsupervised hierarchical clustering of all miRs in lung neutrophils from mice 
that received PBS or S. pneumoniae. The heat map depicts the standardized intensity values for miRs after 
normalization using LVS (left panel) or RMA (right panel) and standardization, with mean expression set at 
zero and expression levels scaled to one standard deviation (bright blue for lower expression levels and bright 
red for high expression levels). Each row represents a sample from a mouse given PBS or S. pneumoniae (as 
labeled) and each column represents a miR. The dendrograms show the results of hierarchical clustering across 
miRs (left side of each panel) or across samples (top of each panel).
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upregulated DE miRs and their predicted target mRNAs that are also DE is shown in Fig. 4a for both correlated 
and anti-correlated DE mRNAs. This same network based on these 7 upregulated DE miRs but including only 
their anti-correlated predicted DE target mRNAs clearly shows that a substantial number of the predicted mRNA 
targets are shared by 2 or more candidate regulatory miRs (Fig. 4b).
A network containing all 37 conserved DE miRs that are downregulated during pneumonia is extremely 
complex and difficult to interpret. Instead, a more tractable network consisting of downregulated conserved miRs 
belonging to 3 miR families and their DE predicted targets was constructed (Fig. 5a). This network shows that 
most of the DE predicted targets were correlated, changing in the same direction as the miRs (Fig. 5a). However, 
there are 227 upregulated predicted target mRNAs, 41 (18%) of which are targeted by 2 or more of the 3 miR 
families (Fig. 5b). Strikingly, 3 DE mRNAs (Eea1, Fndc3a and Zfp281) are predicted targets of all 3 miR families. 
Pathway analysis of the over 200 upregulated DE target mRNAs indicated significant representation of many 
innate immune pathways, including apoptosis involving BCL-2 family members, JAK-STAT signaling, Notch 
signaling, SLC-mediated transport and Toll-like receptor cascades. Thus, these networks based on putative key 
regulatory miRs demonstrate the complexity of miR-mRNA interactions in neutrophils.
DE mRNAs predict miR regulatory hubs. A complementary approach to identify potential miR regulatory hubs 
in lung neutrophils during host response to S. pneumoniae is the miRHub algorithm, which determines whether 
the predicted regulatory effect of any given miR on a set of DE mRNAs is significantly greater than expected 
by chance37, 38. Eleven miR families were identified as candidate regulatory hubs of the downregulated genes 
(Supplementary Table 11); however, five of these were not present on the array. Only one of the remaining six 
candidates was differentially expressed (mmu-miR-96-5p), and it was downregulated during pneumonia in these 
lung neutrophils. Twenty-four different miR families were identified as potential regulatory hubs of the upreg-
ulated mRNAs (Supplementary Table 11). Fourteen individual miRs belonging to six miR families (miR-125a-
5p/125b-5p/351/670/4319, let-7, miR-126-3p, miR-205/205ab, miR-335/335-5p and miR-23abc/23b-3p) were 
downregulated during pneumonia (Supplementary Table 11). The 14 downregulated miRs were predicted to target 
hundreds of upregulated mRNAs. Some of these mRNAs were targeted uniquely by only one of the miRs, whereas 
others were targeted by two or more miRs (Fig. 6). Ten individual miRs out of the 14 miRs belonging to five of the six 
miR families (miR-125a-5p/125b-5p/351/670/4319, let-7, miR-126-3p, miR-335/335-5p and miR-23abc/23b-3p) 
Figure 3. Unsupervised hierarchical clustering of DE miRs in lung neutrophils from mice that received PBS or 
S. pneumoniae. DE miRs were identified using filtering criteria as described in the text after normalization using 
LVS (left panel) or RMA (right panel). The heat map depicts the standardized intensity values for DE miRs after 
standardization.
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Top 25 miRNAs expressed in 
PBS using LVS normalization 
(listed by expression value)
Fold change during 
pneumonia using LVS 
normalization
Top 25 miRNAs expressed in 
PBS using RMA normalization 
(listed by expression value)
Fold change during 
pneumonia using RMA 
normalization
mmu-miR-223-3p 2.1* mmu-miR-223-3p 1.5
mmu-miR-21a-5p 1.3 mmu-miR-3963 −1.3*
mmu-miR-142-3p 1.7 mmu-miR-21a-5p 1.3*
mmu-let-7f-5p −3.4* mmu-miR-126-3p −3.9*
mmu-let-7a-5p −2.4* mmu-miR-142-3p 1.6
mmu-miR-3963 −1.2 mmu-let-7f-5p −2.4*
mmu-miR-126-3p −4.2* mmu-let-7a-5p −1.8*
mmu-let-7c-5p −2.6* mmu-let-7c-5p −2.6*
mmu-miR-26a-5p −2.6* mmu-miR-23a-3p −1.5*
mmu-let-7b-5p −3.2* mmu-miR-26a-5p −2.0*
mmu-miR-15a-5p 1.8* mmu-let-7b-5p −2.3*
mmu-miR-23a-3p −2.1* mmu-miR-29a-3p 1.2
mmu-miR-15b-5p 2.4* mmu-miR-5100c 1.1
mmu-let-7g-5p −1.1 mmu-miR-15b-5p 3.2*
mmu-miR-34b-5p −8.0* mmu-let-7g-5p 1.3*
mmu-miR-24-3p −1.8* mmu-miR-34b-5p −6.7*
mmu-miR-29a-3p −1.0 mmu-miR-16-5p 2.0*
mmu-miR-23b-3p −2.8* mmu-miR-15a-5p 2.3*
mmu-let-7i-5p −1.6* mmu-miR-24-3p −1.5*
mmu-miR-19b-3pa 1.1 mmu-miR-26b-5p 1.1
mmu-miR-26b-5p −1.1 mmu-let-7i-5p −1.1
mmu-miR-16-5p 1.5* mmu-miR-30a-5pd −4.1*
mmu-miR-29c-3p −1.1 mmu-let-7d-5p −2.1*
mmu-let-7d-5p −3.0* mmu-miR-29c-3p 1.1
mmu-miR-107-3pb −1.3 mmu-miR-29b-3p −1.2
Table 2. The 25 most highly expressed miRNAs in lung neutrophils from mice given PBS and the 
corresponding changes in expression during pneumonia. Data were normalized using LVS or RMA. Positive 
(negative) values indicate up (down) regulation of expression compared with PBS. *p ≤ 0.05 compared with 
PBS (FDR corrected). Notes on individual miRs; ammu-miR-19b-3p is ranked 30th in RMA; bmmu-miR-107-3p 
is ranked 41st in RMA; cmmu-miR-5100 was ranked 31st in LVS; dmmu-miR-30a-5p is 42nd in LVS.
Figure 4. (a) Network describing the relationships of the 7 upregulated conserved miRs during pneumonia 
(red triangles) and their DE predicted mRNA targets (ovals, red if upregulated during pneumonia and purple 
if downregulated). (b) The expression of a subset of the DE mRNAs in panel a are anti-correlated with the 
targeting miR.
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were consensus DE miRs, i.e., they were significantly downregulated at least 2-fold during S. pneumoniae pneumo-
nia using both LVS and RMA normalization (Fig. 6 and Supplementary Table 11). The consensus DE miRs whose 
expression is anti-correlated with their DE predicted targets (mmu-miR-125a-5p/mmu-miR-125b-5p, mmu-let-
7b-5p/mmu-let-7c-5p/mmu-let-7d-5p/mmu-let-7e-5p/mmu-let-7f-5p, mmu-miR-126-3p, mmu-miR-335-5p and 
mmu-miR-23b-3p) are designated as candidate key regulatory miRs (miRhubs), which may represent major control 
points in the network-level neutrophil response to S. pneumoniae. These candidate miRhubs are predicted to target 
357 upregulated DE mRNAs (Supplementary Table 12). Of the 357 DE mRNAs, 122 (34%) are shared predicted 
targets of 2 or more of the candidate regulatory miRs (Supplementary Table 13).
Discussion
The present study examined the response of neutrophils in the lungs during pneumonia induced by S. pneumoniae. 
Our previous studies have shown that greater than 98% of these neutrophils migrate out of the pulmonary micro-
vasculature and into the lung tissue or airspace at 24 h after instillation of these bacteria4. Gene profiling shows that 
neutrophils alter their transcriptional profile massively during their response to S. pneumoniae. Pathway analysis 
indicates neutrophils display evidence of activation of immune and host defense pathways (Table 1), particularly 
the upregulation of expression of cytokines, chemokines, cytokine receptors, and pattern recognition receptors 
and adaptor molecules (Supplementary Table 1). The upregulation of many cytokine receptors and downstream 
signaling molecules suggests that neutrophil-derived mediators can act through autocrine or paracrine signaling 
to amplify the neutrophil response. Gene and pathway analysis also show that neutrophils have the potential to 
shape the subsequent adaptive immune response to S. pneumoniae, in part through effects on lymphocyte recruit-
ment and activation. These results support the increasingly appreciated role of neutrophils as sources of cytokines 
and other mediators and as central players in cellular networks involving other immune cells39.
Because of the large number of lung neutrophil mRNAs and miRs that were changed during S. pneumoniae 
pneumonia, evidence of transcription factor activation was pursued by asking whether target genes of particular 
transcription factors were upregulated in these neutrophils. The data suggest that robust activation of a number 
of transcription factors in neutrophils occurs in response to S. pneumoniae in the lungs, including AP-1, Nrf2 
and NF-κB, as assessed by expression of the genes they regulate (Supplementary Table 1). Direct demonstration 
of NF-kB activation in neutrophils using classical biochemical methods has been challenging, likely due to high 
protease activity in neutrophils40. Nrf2 is a redox-sensitive transcription factor encoded by Nfe2l2 that regu-
lates the transcription of antioxidants and other cytoprotective genes41, 42. Because neutrophils can produce large 
amounts of ROS rapidly, Nrf2 appears to play an important role in regulating neutrophil function and survival29. 
The cytokines regulated by these transcription factors, in turn, regulate production of mediators such as the 
chemokines KC and MIP-2.
The signaling pathways that lead to activation of these transcription factors likely include the recognition of 
bacteria or bacterial components by pattern recognition receptors and the binding of inflammatory mediators 
Figure 5. (a) Network showing downregulated miRs (purple triangles) belonging to 3 highly conserved miR 
families and their DE predicted mRNA targets (ovals). (b) The DE predicted targets from panel a that are 
anti-correlated with the miR. Strikingly, 3 DE mRNAs are predicted targets of all 3 miR families: Eea1 (early 
endosome antigen 1), Fndc3a (fibronectin type III domain containing 3A) and Zfp281 (zinc finger protein 281). 
Networks were visualized using Cytoscape. DE mRNAs that are upregulated during pneumonia are colored red, 
whereas downregulated DE mRNAs are colored purple. Gray lines connect DE miRs with their predicted target 
mRNAs.
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to receptors expressed on the neutrophil surface. These transcription factors then target inflammatory medi-
ators, immune modulators, pattern recognition receptors and adaptor molecules, and other transcription fac-
tors. Transcription factors also regulate the expression of miRs, which often silence expression of their target 
genes. Thus, a complex and dynamic web of interactions involving transcription factors and miRs regulates the 
transcriptional response of neutrophils to bacteria in the lungs. Neutrophils are fully capable of responding to 
pathogens and producing the downstream mediators that recruit more neutrophils and modulate host defense in 
numerous ways, including modulation of resolution and initiation of innate immunity30.
This study identified a sizable proportion of neutrophil miRs that are differentially regulated during pneu-
monia induced by S. pneumoniae and may play critical roles in the host response. miRs were identified whose 
expression showed greater than 2-fold change during pneumonia compared with PBS, either upregulated during 
pneumonia (31 miRs) or downregulated (67 miRs). The observed fold changes in DE miRs range from 2-22, with 
the majority of the 98 consensus DE miRs changing less than five-fold (80% and 70% of the DE miRs by LVS and 
RMA, respectively). Importantly, miRs often target overlapping and/or functionally related target genes43, so 
miRs can play a major role in regulating important processes despite modest changes in their expression. Target 
mRNA suppression by microRNAs is affected not only by miR abundance, but also by target site accessibility, 
binding affinity and the ratio of the miR to its target44–46. The majority of the DE mRNAs that were identified as 
putative targets of the upregulated DE miRs showed decreased expression during pneumonia compared with 
PBS (for example, Fig. 4a compared to Fig. 4b). This finding is consistent with the concept that miRs negatively 
regulate expression of their target genes by decreasing mRNA levels, rather than by inhibiting translation47. These 
data support the idea that direct control of targets by upregulated miRs is a prominent regulatory feature of the 
neutrophilic response to S. pneumoniae.
Figure 6. Network depicting downregulated miRs that have been identified as putative key regulatory miRs 
based on the differential expression of their predicted mRNA targets (miRhubs analysis), and their upregulated 
DE predicted targets. Consensus DE miRs that are predicted to regulate many DE mRNAs are depicted as 
purple diamonds. Mmu-miR-126-3p which is a consensus DE miR predicted to target 8 DE mRNAs is depicted 
as a gray oblong. Downregulated miRs that are identified as putative hubs but that are not DE by the filtering 
criteria (miR-mmu-let-7a-5p, mmu-miR-23a-5p, mmu-miR-23a-3p, mmu-miR-205-5p) are also depicted as 
gray oblongs. DE mRNAs that are upregulated during pneumonia are colored red. Gray lines connect miRs with 
their predicted target DE mRNAs.
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To understand integrated regulatory interactions of miRs and mRNAs, candidate regulatory miRs were iden-
tified by constructing networks consisting of DE conserved miRs and their DE predicted targets (Figs 4 and 5). 
These networks demonstrated that potential target DE mRNAs may change in the same or the opposite direc-
tion as the DE miRs. Both also showed that an mRNA is often predicted to be targeted by more than one DE 
miR. We identified a network containing seven upregulated conserved miRs (mmu-miR-1224-5p, mmu-miR-
188-5p, mmu-miR-139-5p, mmu-miR-15b-5p, mmu-miR-721, mmu-miR-18a-5p and mmu-miR-130b-3p) and 
another network consisting of downregulated miRs belonging to 3 highly conserved miR families (let-7, mir-30 
and mir-34).
A complementary approach using miRHub analysis37, 38 identified candidate key regulatory miRs based 
on conserved target sites in DE mRNAs, of which 10 individual miRs are differentially expressed (mmu-miR-
125a-5p/mmu-miR-125b-5p, mmu-let-7a-5p/ mmu-let-7c-5p/mmu-let-7d-5p/mmu-let-7e-5p/mmu-let-7f-5p, 
mmu-miR-126-3p, mmu-miR-335-5p and mmu-miR-23b-3p; see Fig. 6 and Supplementary Tables 8 and 9). Thus, 
each of these approaches identified different candidate key regulatory miRs for the regulation of mRNAs during 
S. pneumoniae pneumonia. Each approach uses a rigorously defined method based upon the most up-to-date 
available computational and biological information. Testing of each potential regulatory miR using in vitro and in 
vivo approaches will be needed to understand these complex systems.
Many of these candidate key regulatory miRs have been identified only recently, and their functions have not 
been studied. Others have been previously identified as prominent regulators of inflammatory pathways, includ-
ing miR-3431,miR-3960 and miR-286148, miR-12649–51 and let-7f52.
These studies assume that neutrophils in bulk reflect individual cell behavior. Whether there are truly dis-
tinct subtypes of neutrophils is unlikely. Differences between neutrophils more likely represent their plasticity, 
similar to that within subpopulations of macrophages, or changes that are part of the aging process in this very 
short-lived cell. No surface markers are known that can be used to discriminate subtypes of neutrophils having 
different functions; thus, cell sorting to study these functions is not feasible. The technology needed for single 
cell sequencing is not yet sufficient to allow studies of transcription within a single neutrophil. This approach will 
clearly be helpful as the technology improves.
In summary, neutrophils are highly responsive to S. pneumoniae by transcribing miRs and mRNAs. This 
dataset of DE miRs and DE mRNAs derived from lung neutrophils was used to identify particular transcription 
factors and cytokines that regulate the inflammatory response and the transition to innate immunity or resolution 
of inflammation. Key pathways were identified, and networks of DE miR-target mRNA interactions were built 
based primarily on computationally derived potential interactions derived from sequence information. These net-
works identified candidate key regulatory miRs. Neutrophils have a short lifespan and cannot be cultured; as such, 
knockdown technologies cannot be effectively employed, making further study of these miR-mRNA interactions 
difficult at the present time. Studies examining mice with conditional deletion of key regulatory miRs may prove 
very exciting. As our biological knowledge of these interactions grows, these networks will become even more 
useful in generating exciting novel testable hypotheses.
Methods
Reagents. Collagenase/ Dispase and Dispase II were purchased from Roche Applied Science (Indianapolis, 
IN); fetal calf serum (FCS) and phosphate buffered saline (PBS) were from Invitrogen (Carlsbad, CA); bovine 
serum albumin (BSA), deoxyribonuclease I from bovine pancreas and Red Blood Cell Lysing Buffer were from 
Sigma-Aldrich (St. Louis, MO). MACs columns, separators, and anti-Ly6G microbead kit were from Miltenyi 
(Auburn, CA). Hema3 fixative and staining solutions were obtained from Fisher Scientific (Kalamazoo, MI, 
USA).
Mice. Adult female C57BL/6 J mice were purchased from Jackson Laboratory (Bar Harbor, ME), and colonies 
were generated. Mice were housed in a specific pathogen-free facility and housed in sterile cages within ventilated 
racks. They received irradiated standard chow and water. Age- and sex-matched mice were studied at 6–8 weeks 
of age. All studies were subject to review by the Institutional Animal Care and Use Committee at the University 
of North Carolina at Chapel Hill and conformed to the Guide for the Care and Use of Laboratory Animals by the 
Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council.
Bacterial pneumonia. Streptococcus pneumoniae (S. pneumoniae; serotype 19, ATCC 49619) was purchased from 
American Type Culture Collection (Manassas, VA). Suspensions of S. pneumoniae were prepared in PBS, and 
the target bacterial dose was estimated based on absorbance of the bacterial suspension at 600 nm (O.D. = 0.9). 
Pneumonia was induced by intratracheal instillation of the bacterial suspension into the left lung at a dose of 
2.3 µl/g mouse body weight29, 53. Colony forming units (CFU) in bacterial suspensions were subsequently deter-
mined by plating serial dilutions of the bacterial suspension on agar plates. The range of CFUs was 1.71–1.88 × 107 
CFU/mouse (mean 1.8 × 107 ± 3.8 × 105 CFU/mouse). Control mice received an equal volume of PBS, in which 
the bacteria were resuspended.
Isolation of single lung cells. Mice were euthanized by isoflurane overdose 24 hours after bacterial instillation. 
The lung vasculature was flushed by perfusing with 10 ml of PBS via the right ventricle, and the lungs and heart 
were removed. Single cell suspensions of lung cells were prepared as described previously4. Dispase II solution 
was instilled into the lungs through the trachea, and the trachea was ligated with silk suture. The samples were 
incubated for 30 minutes at 37 °C. The lungs were excised, minced with scissors and enzymatically digested with 
0.1% collagenase-dispase and 0.01% deoxyribonuclease I in PBS containing 5 mM CaCl2 at 37 °C for 10 min. The 
cells were passed through a 100 µm mesh to remove clumps. The cell suspension was resuspended in red blood 
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cell lysis solution, washed several times with PBS and passed through a 40 µm mesh. The total number of cells 
in each sample was determined using a hemocytometer. Cell differential counts were performed by examining 
cytospins stained with Hema3.
Isolation of neutrophils from single cell suspensions of mouse lungs. Neutrophils were isolated from lung digests 
using Miltenyi’s anti-Ly6G microbead kit according to the manufacturer’s instructions. Briefly, single cell sus-
pensions were prepared from dissected mouse lungs as described above. The cells were washed with PBS con-
taining 2 mM EDTA and 0.5% BSA, and incubated with biotinylated anti-Ly6G and magnetic beads coated with 
anti-biotin. The samples were passed through a column in a magnetic field, and cells bound to beads were col-
lected for further analysis. Cells were kept on ice or at 4–8 °C during processing and isolation. The purity of neu-
trophil isolation was evaluated in the samples from mice with pneumonia, in which the purity was greater than 
97% as determined by examination of stained cytospin preparations. The few contaminating cells usually had 
the appearance of alveolar macrophages and rarely eosinophils. The neutrophil marker Ly6G mRNA was highly 
expressed in every sample.
RNA isolation. Total RNA was extracted from neutrophils using miRNeasy® Mini Kit from Qiagen (Valencia. 
CA).
Microarrays. mRNA expression was profiled using Mouse Gene 1.1 ST arrays (Affymetrix, Santa Clara, CA) 
which cover over 26,000 RefSeq transcripts. miRs were profiled using SurePrint G3 Mouse miRNA 8 × 60 K 
Microarray kits (Agilent, Santa Clara, CA) designed based on miRbase release 17. This approach to profiling 
mRNAs and miRs was selected after a comprehensive evaluation of platforms. Microarrays, RT-qPCR and 
sequencing each has strengths and weaknesses that make each appropriate for specific study goals54. Whereas 
sequencing offers advantages over microarrays or RT-qPCR in that the information extracted with sequencing 
can be more complex, the study by Mestdagh and colleagues showed Agilent arrays performed well compared 
with other hybridization technologies and were best at capturing small expression differences compared with all 
other methods54. The amount of RNA required for high quality next generation sequencing was greater than the 
RNA we could obtain from lung neutrophils isolated from a single mouse with pneumonia. Studies in the litera-
ture show that microarrays fared well compared with other methods and was indeed superior at detecting small 
differences in expression of miRs54.
Real Time-quantitative PCR. Expression of selected mRNAs and miRs was measured in independent samples 
generated from a separate study usingTaqMan mRNA gene expression assays (Thermo Fisher) and Exiqon miR-
cury LNA miRNA assays (Exiqon, Woburn, MA, USA) respectively, according to the manufacturers’ instructions. 
RT-qPCR was performed using the Applied Biosystems 7500 Real-Time System or QuantStudio 6 Flex Real-Time 
PCR System (Thermo Fisher Scientific). Fold changes were calculated using the method described by Livak and 
Schmittgen55.
Flow cytometry. Single cell suspensions were prepared from dissected mouse lungs and stained using 
fluorochrome-conjugated antibodies56 that recognize cell surface markers and the cytokines TNF and IFN-γ 
present intracellularly. Antibodies used were purchased from BioLegend (San Diego, CA, USA) unless indi-
cated otherwise: anti-mouse Ly6G (clone IA8), anti-mouse CD45 (clone 30-F11, BD Biosciences, San Jose, CA, 
USA), anti-mouse CD11b (clone M1/70), anti-mouse CD11c (clone N418), anti-mouse Ly6C (clone AL-21 BD 
Biosciences), anti-mouse MHC Class II I-A/I-E (clone M5/114.15.2), anti-mouse Siglec-F (clone E50-2440, BD 
Biosciences), anti-mouse CD54 (clone 3E2), anti-mouse CD103 (clone M290), anti-mouse IFNγ (XMG1.2), 
anti-mouse TNF (MP6-XT22), anti-mouse CD64 (clone × 54–5/7.1), and anti-mouse CD24 (clone M1/69). After 
gating out debris and doublet cells, neutrophils were identified as single cells expressing both CD45 and Ly6G. 
Flow cytometry was performed using a Cytoflex flow cytometer (Beckman Coulter, Brea, CA, USA) and data 
were analyzed using CytExpert (Beckman Coulter) software.
Microarray data analysis and statistics. Expression signals from Affymetrix mRNA arrays were preprocessed 
and normalized by RMA (Robust Multiarray Average) background correction, GC content and sequence cor-
rection, quantile normalization, and median polish summarization of probe signals mapped to specific genes. 
Custom probeset-to-gene mappings were generated from Affymetrix Probeset and Transcript Annotation release 
35 by consolidating all probesets mapped, in order of preference, to Ensembl 81 gene ID, Refseq mRNA, and 
Genbank accession numbers. miR expression signals were extracted from microarray images using Agilent 
Feature Extraction (FE) software, and normalized using either LVSmiRNA or AgiMicroRna package from 
Bioconductor. These normalization methods were used based on literature suggesting distinct advantages offered 
by each in normalizing gene expression data57–60. LVSmiRNA uses the least-variant set of miRNA to normalize 
between the arrays57, while AgiMicroRna uses RMA.
The normalized log2 transformed intensities were analyzed for differential expression between treat-
ment and control groups by one-way ANOVA. Differentially expressed (DE) miRs or mRNAs were filtered at 
Benjamini-Hochberg FDR adjusted p value or q-value < 0.05, and fold change >2. Fold change, expression level 
and p value were used as filtering criteria to identify possible candidate key miRs. These criteria were imple-
mented based on a comprehensive study by the SEQC/MAQC-III consortium showing that relative expression 
measurements agreed fairly well across different expression profiling platforms and study sites after filtering for 
fold change, p value and expression level61. For miRs, the analyses were carried out on both LVS and RMA nor-
malized log2 intensities in parallel. The consensus DE miRs between LVS and RMA were used in subsequent 
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network analysis. Expression analyses were performed using Partek Genomics Suites v6.5 (Partek, Inc., St. Louis, 
MO). To identify pathways or functions that are significantly altered during S. pneumoniae pneumonia, Gene 
Set Enrichment Analysis (GSEA) using Gene Ontology (GO) biological process terms from mRNA expression 
data was performed according to the method described by Subramanian, Tamayo and colleagues62, 63. Gene 
ontology, biological functions and pathways and transcription factor binding sites were analyzed using DAVID 
Bioinformatics Resources64, 65 (NIAID, NIH) and InnateDB66.
To identify potential functionally significant miR-mRNA interactions, lists of target genes (mRNAs) were 
constructed for each DE miR based on predicted targets in the 3′-UTR of all genes using TargetScanMouse release 
7.1 (TS7) as source for miR targets67. TargetScan predictions are based on the identification of 6-, 7- or 8-mer 
sequences in the 3′UTR of target mRNAs that are complementary to the seed region of miRs. miRs are grouped 
into families that share a common seed sequence, suggesting similar or closely related targets and functions. 
TargetScan classifies miR families as broadly conserved (expressed across most vertebrates, usually to zebrafish), 
conserved (expressed across most mammals, but usually not beyond placental mammals) or poorly conserved 
(comprising all remaining miRs).
Networks of miR-target connections between DE miRs and DE mRNAs were compiled from TS7 target 
predictions and miR family information downloaded from miRBase21. The networks were visualized using 
Cytoscape software68.
Candidate miR regulatory hubs were identified by miRHub37, 38, using the “non-network” mode and requiring 
a predicted target site to be conserved among at least three mammalian species including mouse. This algorithm 
determines whether the predicted regulatory effect of any given miR on a set of DE genes is significantly greater 
than expected by chance.
Online Supplementary Material is included.
Availability of materials and data. Microarray data have been deposited in Gene Expression Omnibus 
under accession number GSE97922 (http://www.ncbi.nlm.nih.gov/geo/).
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